How do hormonal changes affect RSD symptoms in ADHD?Â
Many people with ADHD notice that their emotions feel harder to manage during certain times of the month or life stages. For some, this includes intense emotional pain or rejection sensitivity, often described as Rejection Sensitive Dysphoria (RSD). Emerging evidence suggests that hormonal fluctuations may amplify these experiences by affecting the same brain circuits involved in ADHD.
How hormones influence emotional regulation in ADHD
The hormones oestrogen, progesterone, and cortisol all play key roles in how the brain regulates mood and emotional control. According to Frontiers in Psychiatry (2022), oestrogen helps the prefrontal cortex and amygdala communicate more effectively by increasing dopamine and serotonin activity, which supports focus and emotional stability. When oestrogen levels drop, such as before menstruation or during perimenopause, these circuits function less efficiently, leading to stronger emotional reactions and reduced stress tolerance. Progesterone and cortisol fluctuations can also heighten anxiety, irritability, and rejection sensitivity, particularly when oestrogen is low (Gurvich et al., 2022).
Hormonal transitions and RSD-like symptoms
A 2025 Frontiers in Global Women’s Health review by the Eunethydis ADHD group found that women with ADHD experience more severe symptoms during hormonal transitions such as puberty, menstruation, postpartum, and perimenopause. Low-oestrogen phases were linked to greater emotional lability, inattention, and rejection sensitivity, while some also reported that stimulant medication felt less effective during these times (Eunethydis, 2025).
What NHS and NICE say
While current NICE guidance (NG87, 2025) does not yet include specific advice for menstrual or menopause-related ADHD symptoms, it recognises emotional dysregulation as a major feature of ADHD and recommends psychological and behavioural support where symptoms fluctuate (NICE NG87). The NHS England ADHD Taskforce Report (2025) also highlights that women with ADHD are under-recognised and that more research is needed into hormonal and emotional symptom patterns (NHS England, 2025).
Getting help and support
Tracking symptoms across the menstrual cycle or during menopause can help identify hormone-related changes in mood or sensitivity. For assessment or medication review, NHS and private services such as ADHD Certify can provide structured evaluations and post-diagnostic care with qualified clinicians in the UK.
Takeaway
Hormonal fluctuations can intensify emotional sensitivity and rejection distress in ADHD by disrupting prefrontal–amygdala regulation and dopamine balance. Recognising these patterns can help individuals and clinicians tailor support, medication timing, and emotional management strategies more effectively across hormonal phases.
